Skip to main content

Table 4 Diagnostic Capabilities of MCB tests by Age

From: The feasibility and diagnostic accuracy by multiple cardiac biomarkers in emergency chest pain patients: a clinical analysis to compare 290 suspected acute coronary syndrome cases stratified by age and gender in Taiwan

 

Patient of Age

P value

Patients ≥65 years

Patients <65 years

Sensitivity

80.0 % (64.1–90.0)

52.6 % (37.3–67.5)

<0.05*

Specificity

44.1 % (35.3–53.4)

84.9 % (76.9–90.5)

<0.05*

PPV

31.1 % (22.5–41.3)

55.6 % (39.6–70.5)

<0.05*

NPV

87.5 % (76.4–93.8)

83.3 % (75.2–89.2)

0.28

LR+

1.43 (1.13–1.81)

3.49 (2.02–6.00)

 

LR−

0.45 (0.22–0.91)

0.56 (0.39–0.79)

 
  1. PS: PPV, NPV, LR+ and LR− mean positive and negative predictive values, positive and negative likelihood ratios, respectively
  2. *mean P < 0.05